The B lymphocyte as an immunotherapeutic target.
Fearon
D T
DT
Department of Medicine, University of Cambridge School of Clinical Medicine, UK.
D015703:Antigens, CD / Q000276:immunology; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology* / Q000502:physiology; D019013:CD40 Antigens; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008213:Lymphocyte Activation / Q000276:immunology; D017464:Receptors, Complement 3d / Q000276:immunology; D017452:Receptors, IgG / Q000276:immunology
D015703:Antigens, CD; D018941:Antigens, CD19; D000944:Antigens, Differentiation, B-Lymphocyte; D019013:CD40 Antigens; D017464:Receptors, Complement 3d; D017452:Receptors, IgG